Veri Medtech Holdings, Inc. VRHI
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -28.15% | -25.51% | -32.34% | -37.04% | -37.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -28.15% | -25.51% | -32.34% | -37.04% | -37.43% |
| Cost of Revenue | -22.69% | -29.79% | -39.28% | -38.61% | -39.91% |
| Gross Profit | -29.95% | -24.08% | -29.58% | -36.55% | -36.57% |
| SG&A Expenses | -35.40% | -20.13% | 9.56% | -23.45% | -24.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.83% | -22.51% | -4.00% | -26.92% | -27.89% |
| Operating Income | 53.35% | -135.53% | -1,051.97% | -202.06% | -117.39% |
| Income Before Tax | 55.74% | -116.60% | -652.07% | -175.52% | -112.07% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 55.74% | -169.91% | -652.07% | -175.52% | -112.07% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.74% | -169.91% | -652.07% | -175.52% | -112.07% |
| EBIT | 53.35% | -135.53% | -1,051.97% | -202.06% | -117.39% |
| EBITDA | 53.51% | -139.57% | -1,072.90% | -203.71% | -117.85% |
| EPS Basic | 55.79% | -55.28% | -331.63% | -58.47% | -22.01% |
| Normalized Basic EPS | 52.58% | -23.76% | -333.33% | -58.48% | -21.91% |
| EPS Diluted | 55.79% | -55.28% | -331.63% | -58.47% | -22.01% |
| Normalized Diluted EPS | 52.58% | -23.76% | -333.33% | -58.48% | -21.91% |
| Average Basic Shares Outstanding | 0.00% | 73.91% | 73.92% | 73.91% | 73.91% |
| Average Diluted Shares Outstanding | 0.00% | 73.91% | 73.92% | 73.91% | 73.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |